Shital S. Bhanushali Increases Stake in Caprolactam Chemicals to 7.83%

1 min read     Updated on 20 Nov 2025, 05:51 PM
scanx
Reviewed by
Shriram SScanX News Team
Overview

Shital S. Bhanushali, a promoter of Caprolactam Chemicals Limited, has acquired 5,420 additional shares through an open market purchase. This acquisition has increased Bhanushali's total shareholding to 360,022 shares, representing 7.83% of the company. The transaction was completed on 28.11.2025 and reported in compliance with SEBI regulations.

25186879

*this image is generated using AI for illustrative purposes only.

Caprolactam Chemicals Limited , a company listed on the BSE, has reported a significant change in its shareholding pattern following a recent acquisition by one of its promoters. Shital S. Bhanushali, a key stakeholder in the company, has substantially increased their ownership through an open market purchase.

Acquisition Details

Shital S. Bhanushali acquired an additional 5,420 shares of Caprolactam Chemicals Limited through an open market transaction. This acquisition has resulted in a notable increase in their total shareholding, as detailed below:

Aspect After Acquisition
Number of Shares 360,022
Shareholding Percentage 7.83%

The transaction was completed on 28.11.2025 and disclosed in accordance with SEBI (Substantial Acquisition of Shares and Takeovers) Regulations.

Impact on Promoter Holding

This acquisition reinforces the promoter's commitment to the company and significantly increases their stake. The exact shareholding percentages of other promoters are not provided in the available information.

Company Overview

Caprolactam Chemicals Limited is a chemical company listed on the BSE. The recent acquisition by Shital S. Bhanushali demonstrates continued interest and investment from the promoter group in the company.

This acquisition and the resulting change in shareholding pattern have been duly reported to the stock exchange, maintaining transparency in line with regulatory requirements.

Historical Stock Returns for Caprolactam Chemicals

1 Day5 Days1 Month6 Months1 Year5 Years
+4.95%-0.55%+27.13%+50.09%+15.28%+234.73%
Caprolactam Chemicals
View in Depthredirect
like20
dislike

Caprolactam Chemicals Shareholders Approve Key Leadership Reappointments and New Auditor

1 min read     Updated on 25 Sept 2025, 02:46 PM
scanx
Reviewed by
Riya DScanX News Team
Overview

Caprolactam Chemicals' 36th AGM saw shareholders approve several significant appointments. Ms. Zaver Shankarlal Bhanushali was reappointed as Managing Director for a five-year term from August 7, 2025, to August 6, 2030. Mr. Siddharth Shankarlal Bhanushali was reappointed as Whole Time Director and CFO for the same period. M/s. Alpi Nehra and Associates were appointed as Secretarial Auditors for five years. The Bhanushali family maintains strong leadership roles in the company, with Ms. Zaver being Mr. Siddharth's mother.

20337413

*this image is generated using AI for illustrative purposes only.

Caprolactam Chemicals , a prominent player in the chemical industry, held its 36th Annual General Meeting (AGM) on September 25, 2025, where shareholders approved several significant appointments and reappointments.

Leadership Continuity

The shareholders gave their nod to the reappointment of Ms. Zaver Shankarlal Bhanushali as the company's Managing Director for another five-year term. Her new tenure will run from August 7, 2025, to August 6, 2030. Ms. Bhanushali brings 22 years of management experience to the role and has been instrumental in handling the company's day-to-day operations and procurement activities.

In a move that ensures continuity in the company's financial leadership, Mr. Siddharth Shankarlal Bhanushali was reappointed as Whole Time Director and Chief Financial Officer (CFO) for a five-year term coinciding with that of Ms. Bhanushali. Mr. Siddharth Bhanushali, a Chemical Engineer who graduated from the University of Sydney in 2002, brings 15 years of chemical industry experience to his role.

New Secretarial Auditor

The shareholders also approved the appointment of M/s. Alpi Nehra and Associates as the company's Secretarial Auditors for a five-year term, commencing from the conclusion of the AGM.

Board Recommendations and Regulatory Compliance

These appointments and reappointments were previously recommended by the company's Board of Directors. Caprolactam Chemicals has confirmed that both Ms. Zaver Bhanushali and Mr. Siddharth Bhanushali are not debarred from holding office by any regulatory authority, ensuring compliance with corporate governance standards.

Family Leadership

The reappointments highlight the continued involvement of the Bhanushali family in the company's top management. Ms. Zaver Shankarlal Bhanushali is the mother of Mr. Siddharth Shankarlal Bhanushali, creating a strong family leadership structure at the helm of Caprolactam Chemicals.

These approvals by the shareholders demonstrate confidence in the current leadership and their vision for the company's future. As Caprolactam Chemicals moves forward with its experienced management team, stakeholders will be watching closely to see how these leaders steer the company through the evolving landscape of the chemical industry.

Historical Stock Returns for Caprolactam Chemicals

1 Day5 Days1 Month6 Months1 Year5 Years
+4.95%-0.55%+27.13%+50.09%+15.28%+234.73%
Caprolactam Chemicals
View in Depthredirect
like15
dislike
More News on Caprolactam Chemicals
Explore Other Articles
59.75
+2.82
(+4.95%)